Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Merger Agreement [Member] Legal Entity [Axis] OWP Ventures, Inc. [Member] Subscriptions Receivable [Member] Accumulated Other Comprehensive Income (Loss) [Member] Noncontrolling Interest [Member] Title of Individual [Axis] CEO [Member] Debt Instrument [Axis] Promissory Notes [Member] Fair Value Hierarchy and NAV [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Property, Plant and Equipment, Type [Axis] Office Equipment [Member] Furniture and Fixtures [Member] Software [Member] Construction in Progress [Member] Convertible Note Payable One [Member] Convertible Note Payable Two [Member] CSW Ventures, LP [Member] Short-Term Unsecured Demand Loans One[Member] Short-Term Unsecured Demand Loans Two [Member] Short-Term Unsecured Demand Loans [Member] Notes Payable [Member] Notes Payable One [Member] Notes Payable Two [Member] Unsecured Promissory Note [Member] One World Pharma, Inc [Member] One World Pharma S.A.S. [Member] Service Provider [Member] Scenario [Axis] One-Year Anniversary [Member] Director [Member] Service Provider One [Member] Consultant [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Sanguine Group LLC [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Other current assets Inventory Total current assets Right-of-use asset, net Security deposits Fixed assets, net Total Assets Liabilities and Stockholders' Equity (Deficit) Current liabilities: Accounts payable Accrued expenses Current portion of lease liability Convertible note payable Advances from shareholders Notes payable Total current liabilities Long-term lease liability Total Liabilities Stockholders' Equity (Deficit): Common stock, $0.001 par value, 75,000,000 shares authorized; 39,922,899 and 34,291,905 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively Additional paid-in capital Subscriptions receivable, consisting of 6,012,500 shares at December 31, 2018 Accumulated other comprehensive loss Accumulated (deficit) Total Stockholders' Equity Noncontrolling Interest Total Stockholders' Equity (Deficit) Total Liabilities and Stockholders' Equity (Deficit) Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Subscriptions receivable, shares Income Statement [Abstract] Revenue: Expenses: General and administrative Professional fees Total operating expenses Operating loss Other income (expense): Interest income Interest expense Total other expense Net loss Other comprehensive loss: Loss on foreign currency translation Net other comprehensive loss Weighted average number of common shares outstanding - basic and fully diluted Net loss per share - basic and fully diluted Statement [Table] Statement [Line Items] Balance Balance, shares Consolidation of One World Pharma, Inc. Contributed capital on related party acquisition of One World Pharma S.A.S. Common stock sold for cash Common stock sold for cash, shares Common stock issued for services Common stock issued for services, shares Common stock issued for purchase of One World Pharma S.A.S. Common stock issued for purchase of One World Pharma S.A.S, shares Contributed capital Beneficial conversion feature on convertible note Cash received on subscriptions receivable of OWP Ventures, Inc. Common stock of OWP Ventures, Inc. sold for cash Common stock of OWP Ventures, Inc. sold for cash, shares Issuance of common stock of OWP Ventures, Inc. on debt conversion Issuance of common stock of OWP Ventures, Inc. on debt conversion, shares Common stock issued for services, OWP Ventures, Inc Common stock issued for services, OWP Ventures, Inc, shares Amortization of common stock options issued for services, OWP Ventures, Inc Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1) Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1), shares Common stock cancelled pursuant to merger with OWP Ventures, Inc Common stock cancelled pursuant to merger with OWP Ventures, Inc, shares Amortization of common stock options issued for services Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense Debt discounts Stock-based compensation Amortization of options issued for services Decrease (increase) in assets: Other current assets Inventory Right-of-use assets Security deposits Increase (decrease) in liabilities: Accounts payable Accrued expenses Lease liability Net cash used in operating activities Cash flows from investing activities Purchase of fixed assets Net cash used in investing activities Cash flows from financing activities Proceeds from convertible note payable Repayment of advances from shareholders Proceeds from subscriptions receivable Proceeds from sale of common stock Net cash provided by financing activities Effect of exchange rate changes on cash Net increase (decrease) in cash Cash - beginning Cash - ending Supplemental disclosures: Interest paid Income taxes paid Non-cash investing and financing transactions: Fair value of net assets acquired in merger Value of shares issued for conv of debt Beneficial conversion feature Founders shares issued on subscriptions receivable Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Business and Significant Accounting Policies Going Concern Business Combinations [Abstract] Reverse Merger Related Party Transactions [Abstract] Related Party Transactions Investments, All Other Investments [Abstract] Fair Value of Financial Instruments Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Other Current Assets Property, Plant and Equipment [Abstract] Fixed Assets Payables and Accruals [Abstract] Accrued Expenses Debt Disclosure [Abstract] Convertible Note Payable Advances from Shareholders Notes Payable Leases [Abstract] Leases Equity [Abstract] Changes in Stockholders' Equity Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Accounting Policies [Abstract] Nature of Business Basis of Presentation Principles of Consolidation Foreign Currency Translation Comprehensive Income Use of Estimates Segment Reporting Fair Value of Financial Instruments Cash and Cash Equivalents Cash in Excess of FDIC Insured Limits Revenue Recognition Inventory Stock-based Compensation Basic and Diluted Loss Per Share Adoption of New Accounting Standards and Recently Issued Accounting Pronouncements Schedule of Common Control and Ownership Interest Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Schedule of Other Current Assets Schedule of Fixed Assets Schedule of Accrued Expenses Schedule of Convertible Note Payable Schedule of Advances from Shareholders Schedule of Notes Payable Schedule of Components of Lease Expense Schedule of Supplemental Balance Sheet Information Related to Leases Schedule of Supplemental Cash Flow Related to Leases Schedule of Finance Lease Liability Maturity Number of stock issued Options to purchase common stock Common stock exercise price Proceeds from issuance convertible note Conversion price Number of shares cancelled Nature of business, description Number of operating segments FDIC insured amount Cash in excess of FDIC Name of Entity State of Incorporation Relationship Cash on hand Working capital Accumulated deficit Repayment of loan from related party Advance from affiliates Interest rate Debt principal amount Proceeds from private offering Cash Right-of-use asset Total assets Convertible note payable Advances from shareholders Notes payable Lease liability Total liabilities Total assets and liabilities Security deposit Prepaid expenses Other receivables Total Fixed assets, gross Less: accumulated depreciation Total Accrued payroll Accrued withholding taxes Accrued ICA fees and contributions Accrued interest Deferred rent obligations Accrued Expenses Debt discount Finance expense Common stock percentage Interest expense Interest expense related to the debt discount Convertible note payable, gross Less: unamortized debt discounts Convertible note payable Proceeds from convertible debt Debt interest rate Number of shares issued Stock split ratio Proceeds from equity securities Conversion price percentage Debt maturity date Debt converted into shares Interest expense Total advances from shareholders Total notes payable Proceeds from notes payable Finance lease cost: Amortization of assets Finance lease cost: Interest on lease liabilities Total lease cost Finance lease: Right-of-use asset Finance lease: Accumulated amortization Right-of-use asset, net Current portion of finance lease liability Long-term finance lease liability Total finance lease liability Weighted average remaining lease term: Operating leases Weighted average remaining lease term: Finance leases Weighted average discount rate: Operating leases Weighted average discount rate: Finance leases Operating cash flows used for finance leases Total operating lease liabilities Total finance lease liabilities 2019 2020 2021 2022 2023 Thereafter Total Less interest Present value of lease liabilities Less current portion Long-term lease liabilities Reverse stock split, description Reverse stock split, conversion ratio Cash received on subscriptions receivable Number of stock sold Sale of stock price per share Number of stock sold, value Number of common stock issued for debt conversion Value common stock issued for debt conversion Debt interest amount Number of stock issued for services Number of stock issued for services, value Options to purchase common stock Options exercise price Number of options vested Number of stock issued Federal net operating losses Net operating loss carry forwards, expire year Repayments of Advances from Shareholders Nature Of Business [Policy Text Block] Merger Agreement [Member] OWP Ventures, Inc. [Member] Mr. Lei Wang [Member] Subscriptions Receivable [Member] Consolidation of additional paid in capital. Contributed capital on related party acquisition. Common stock sold for cash. Common stock sold for cash, shares. Amortization of common stock options issued for services. Amortization of common stock options issued for services. Cash received on subscriptions receivable. Amortization of options issued for services. Increase decrease in right of use assets. Increase decrease in lease liabilities. Proceeds from subscriptions receivable. Advances from Shareholders [Text Block] Notes Payable [Text Block] Cash in Excess of FDIC Insured Limits [Policy Text Block] Schedule of Common Control and Ownership Interest [Table Text Block] Schedule of Supplemental Balance Sheet Information Related to Leases [Table Text Block] Schedule of Supplemental Cash Flow Related to Leases [Table Text Block] Working capital. CEO [Member] Promissory Notes [Member] Right-of-use asset fair value disclosure. Advances from shareholders fair value disclosure. Lease liability fair value disclosure. Accrued fees and contributions. Interest expense related to the debt discount. Convertible Note Payable One [Member] Convertible Note Payable Two [Member] CSW Ventures, LP [Member] Short-Term Unsecured Demand Loans One [Member] Short-Term Unsecured Demand Loans Two [Member] Short-Term Unsecured Demand Loans [Member] Notes Payable [Member] Notes Payable One [Member] Notes Payable Two [Member] Unsecured Promissory Note [Member] Relationship. One World Pharma, Inc [Member] One World Pharma S.A.S. [Member] Finance lease: Right-of-use asset. Finance lease: Accumulated amortization. Operating cash flows used for finance leases. Service Provider [Member] One-Year Anniversary [Member] Service Provider One [Member] Consultant [Member] Net operating loss carry forwards, expire year. Beneficial conversion feature. February 4, 2019 [Member] Sanguine Group LLC [Member] Common stock issued for services. Common stock issued for services, shares. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Common Stock, Value, Subscriptions Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Expenses Operating Income (Loss) Other Nonoperating Expense Other Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Other Current Assets Increase (Decrease) in Inventories IncreaseDecreaseInRightOfUseAssets Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Fair Value of Financial Instruments, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Cash and Cash Equivalents, Fair Value Disclosure Convertible Debt, Fair Value Disclosures AdvanceFromShareholdersFairValueDisclosures Notes Payable, Fair Value Disclosure LeaseLiabilityFairValueDisclosures Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Long-term Debt Interest Expense, Related Party Lease, Cost FinanceLeaseAccumulatedAmortization Finance Lease, Right-of-Use Asset Finance Lease, Liability Capital Leases, Future Minimum Payments Due Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross